Last reviewed · How we verify

NCT05705115: Volu-Flow

Acetated Ringer´s Solution in Experimental Hypovolemia

Status unknown Phase 4 Last updated 5 March 2024
What this trial tests

Phase 4 trial testing Ringer acetate in Hypovolemia in 12 participants. Status unknown.

Timeline
2 March 2024
Primary endpoint
29 July 2024
29 July 2024

Quick facts

Lead sponsorOslo University Hospital
PhasePhase 4
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposebasic science
Enrollment12
Start date2 March 2024
Primary completion29 July 2024
Estimated completion29 July 2024
Sites1 location across Norway

Drugs / interventions tested

Conditions studied

Sponsor

Oslo University Hospital

Who can join

Adults 18 to 40, any sex, with Hypovolemia or Fluid Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Intravenous fluids are often given to increase stroke volume and thereby improve global oxygen delivery. The effect is however often transient, but the effect of a fluid bolus on stroke volume and other hemodynamic variables over time are poorly described. The volume effect of a fluid bolus (effect on blood volume) can be calculated by measuring Haemoglobin. The purpose of this study is to elucidate the hemodynamic effects of a fluid bolus during normovolemia and hypovolemia in healthy volunteers. Study details include: • Study Duration: 2 visits of approximately 2 h duration each + follow-up visit. Visits 1 and 2 are at least 2 days apart. Number of Participants: A maximum of 15 participants will be enrolled to study intervention such that 12 evaluable participants complete the study

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Ringer acetate

Trials testing the same drug.

Other recruiting trials for Hypovolemia

Currently open trials in the same condition.

Other Oslo University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05705115.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing